[
  {
    "ts": null,
    "headline": "Why Is McKesson (MCK) Down 5.2% Since Last Earnings Report?",
    "summary": "McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=2fc274c22ab32080e5478ea6babf933272c8c3a5bda736ef09369511bad97502",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764952209,
      "headline": "Why Is McKesson (MCK) Down 5.2% Since Last Earnings Report?",
      "id": 137715840,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=2fc274c22ab32080e5478ea6babf933272c8c3a5bda736ef09369511bad97502"
    }
  },
  {
    "ts": null,
    "headline": "The Bull Case For West Pharmaceutical Services (WST) Could Change Following Margin Squeeze And Slower Revenue Growth",
    "summary": "West Pharmaceutical Services recently reported that its annual revenue growth over the past two years was about 1.5%, while rising costs compressed its adjusted operating margin by 5.5 percentage points and weakened returns on capital, highlighting pressure on its core injectable packaging and delivery businesses. This combination of slowing top-line expansion and margin erosion raises questions about whether the company’s traditional profit engines can continue to support its long-term...",
    "url": "https://finnhub.io/api/news?id=2c7e1dac4b21a3c02655f402fd1672274d3bc597f484ccd35e0aecb075d39d7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764932937,
      "headline": "The Bull Case For West Pharmaceutical Services (WST) Could Change Following Margin Squeeze And Slower Revenue Growth",
      "id": 137697743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services recently reported that its annual revenue growth over the past two years was about 1.5%, while rising costs compressed its adjusted operating margin by 5.5 percentage points and weakened returns on capital, highlighting pressure on its core injectable packaging and delivery businesses. This combination of slowing top-line expansion and margin erosion raises questions about whether the company’s traditional profit engines can continue to support its long-term...",
      "url": "https://finnhub.io/api/news?id=2c7e1dac4b21a3c02655f402fd1672274d3bc597f484ccd35e0aecb075d39d7a"
    }
  }
]